Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
530K
-
Shares change
-
+73.6K
-
Total reported value, excl. options
-
$13.3M
-
Value change
-
+$1.84M
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$25.00
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2015
9 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q1 2015.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 530K shares
.
Largest 9 shareholders include Parametric Portfolio Associates LLC (299K shares), RMB Capital Management, LLC (91.5K shares), World Asset Management Inc (80.2K shares), GLENMEDE TRUST CO NA (25.1K shares), Ameriprise Financial Inc (18.1K shares), Calvert Investment Management Inc. (14.8K shares), Hexavest Inc. (1.13K shares), REILLY FINANCIAL ADVISORS, LLC (200 shares), and PNC Financial Services Group, Inc. (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.